Biosyngen - Crunchbase Company Profile & Funding

Q: Who invested in Biosyngen?

Biosyngen is funded by SCI Group.

Q: When was the last funding round for Biosyngen?

Biosyngen closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Biosyngen raised to date?

Biosyngen has raised obfuscated.

Overview

Biosyngen

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Biosyngen

CB Rank

70174

Biosyngen is scientific research company.

Founded

obfuscation

Private

Venture - Series Unknown

Singapore, Central Region, Singapore

51-100

www.biosyngen.com

Biotechnology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Victor Lietao: Founder & CEO
Deping Han: Chief Executive Officer

Details

Legal Name

Biosyngen Pte. Ltd.

Operating Status

Active

Company Type

For Profit

Founders

Victor Lietao

About the Company

Biosyngen is developing multiple T-cell immunotherapies with the aim to address a wide range of malignancies. BioSyngen Group is dedicated in the clinical and commercial transfer of innovative immune-cell therapy technologies and products. It develops immune cell therapies for aggaressive cancers.

Phone Number

+65 6914 9306

Contact Email

info@biosg.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

BRG01

An autologous CAR-T cell therapy in Phase II clinical trials targeting nasopharyngeal cancer and EBV-positive lymphoma, designed to address solid tumors with enhanced safety and efficacy.

BRL03

A TCR-T cell therapy in Phase I clinical trials targeting multiple solid tumors including lung cancer, designed to enhance T cell persistence and specificity against tumor antigens.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Biosyngen	1	obfuscated obfuscation	SCI Group	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
SCI Group	Yes	Venture Round - Biosyngen	Zhang Qiong
SCI Group	Yes	Venture Round - Biosyngen	Zhang Qiong
SCI Group	Yes	Venture Round - Biosyngen	Zhang Qiong
SCI Group	Yes	Venture Round - Biosyngen	Zhang Qiong
SCI Group	Yes	Venture Round - Biosyngen	Zhang Qiong